NTEC
(NASDAQ)
0.3900
+0.0403  (+10.33%)
Volume (24h): 18.57M Day Range: 0.3342 - 0.4174
Market Cap: 27.01M 52W Range: 0.1324 - 5.22
May-28-20 12:00PM Intec Pharma to Present at Jefferies Virtual Healthcare ConferencePR Newswire
May-11-20 08:15PM Intec Pharma Reports First Quarter 2020 Financial Results and Provides Corporate UpdatePR Newswire
May-04-20 07:33PM Intec Pharma Announces $5.0 Million Registered Direct OfferingGlobeNewswire
12:11PM New Strong Buy Stocks for May 4thZacks
Mar-13-20 11:30AM Intec Pharma Reports Fourth Quarter and Year End 2019 Financial Results and Corporate UpdatePR Newswire
Feb-25-20 12:30PM Intec Pharma to Participate at Three Investment Conferences in MarchPR Newswire
Jan-31-20 08:45PM Top Marijuana Stocks on the NASDAQInvestopedia
03:44AM Intec Pharma Announces Pricing of $6.5 Million Public OfferingGlobeNewswire
Jan-30-20 09:11PM Intec Pharma Announces Proposed Public OfferingPR Newswire
Jan-09-20 12:00PM Intec Pharma Issues Letter to ShareholdersPR Newswire
Dec-24-19 12:51AM Hedge Funds Aren’t Crazy About Intec Pharma Ltd (NTEC) AnymoreInsider Monkey
Dec-11-19 12:30PM Intec Pharma Provides Update on Novartis Feasibility and Option AgreementPR Newswire
Dec-06-19 12:30PM Intec Pharma to Present at LD Micro's 12th Annual Main EventPR Newswire
Dec-03-19 12:30PM Intec Pharma Announces $10 Million Ordinary Shares Purchase Agreement With Aspire CapitalPR Newswire
Nov-13-19 12:00PM Intec Pharma to Participate in Jefferies London Healthcare ConferencePR Newswire
Nov-12-19 12:00PM Intec Pharma Reports Third Quarter 2019 Financial Results and Provides Business UpdatePR Newswire
Oct-26-19 10:01PM Top Marijuana Stocks on the NASDAQInvestopedia
Sep-25-19 11:00AM Intec Pharma Highlights Potential of Accordion Pill® Oral Drug Delivery Platform in Two Posters at International Congress of Parkinson's and Movement Disorder SocietyPR Newswire
Sep-16-19 11:00AM Intec Pharma to Present Two Posters at International Congress of Parkinson's and Movement Disorder SocietyPR Newswire
Sep-03-19 11:00AM Intec Pharma to Participate in September Investment ConferencesPR Newswire
Aug-30-19 12:52PM Implied Volatility Surging for Intec Pharma (NTEC) Stock OptionsZacks
Aug-13-19 02:09PM Can European Expansion Aid Canopy Growth (CGC) Q1 Earnings?Zacks
Aug-09-19 11:00AM Intec Pharma Reports Second Quarter 2019 Financial Results and Business UpdatePR Newswire
Aug-06-19 04:00PM ArQule (ARQL) to Post Q2 Earnings: What's in the Cards?Zacks
Jul-23-19 02:50PM Why Did Intec Pharma Crash on Monday?Market Realist
11:26AM The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy DesignationBenzinga
Jul-22-19 02:15PM Intec Shares Slammed As Advanced Parkinson's Disease Drug Combo Flunks Late-Stage StudyBenzinga
11:00AM Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease PatientsPR Newswire
Jul-03-19 09:00PM Horizons ETFs Rebalances Marijuana-Focused ETFsCNW Group
Jul-01-19 01:00PM Intec Pharma Announces Publication of Article Reviewing Accordion Pill's Unique Gastric Retention Platform in Therapeutic DeliveryPR Newswire
Jun-28-19 09:45PM Here’s What Hedge Funds Think About Intec Pharma Ltd (NTEC)Insider Monkey
Jun-25-19 11:00AM Intec Pharma Announces Results from Earlier Phase 2 Clinical Trial of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients Published in Parkinsonism and Related DisordersPR Newswire
Jun-19-19 11:00AM Intec Pharma Announces Results From Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Were Presented at the XXIV World Congress on Parkinson's Disease and Related DisordersPR Newswire
May-28-19 11:00AM Intec Pharma to Participate at June Investment ConferencesPR Newswire
May-20-19 11:00AM Intec Pharma Granted European PatentPR Newswire
May-16-19 10:00AM Intec Pharma Announces Research Collaboration Agreement With MerckPR Newswire
May-07-19 11:00AM Intec Pharma Reports First Quarter 2019 Financial Results and Corporate UpdatePR Newswire
May-02-19 11:00AM Intec Pharma's Data from Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Accepted for Presentation at the XXIV World Congress on Parkinson's Disease and Related DisordersPR Newswire
Apr-30-19 11:00AM Intec Pharma Reports Last Patient Last Visit in Pivotal Phase 3 Trial of Accordion Pill™ Carbidopa/Levodopa for the Treatment of Advanced Parkinson's Disease PatientsPR Newswire
Apr-24-19 03:30PM The New Cannabis ETF Is Already Making AdditionsBenzinga
Mar-27-19 10:00AM A Trio of Indirect Cannabis PlaysMoneyShow
Feb-20-19 03:03PM Biotech Stock Roundup: ICPT Strong on NASH Drug Data, Collaborations & MoreZacks
Jan-04-19 12:00PM Cannabis Stock News Daily Roundup January 4Market Exclusive
Dec-23-18 07:39AM Should You Buy Intec Pharma Ltd (NTEC)?Insider Monkey
Dec-13-18 02:15PM Morning Rally Bends but Doesn't BreakZacks
Dec-11-18 03:37PM Is Intec Pharma a Sleeping Blockbuster Play?GuruFocus.com
Dec-03-18 11:50AM Today's Research Reports on Trending Tickers: Oragenics and Intec PharmaACCESSWIRE
Nov-21-18 01:55PM Analysis: Positioning to Benefit within KemPharm, Bellerophon Therapeutics, Exela Technologies, Intec Pharma, Cerecor, and Chiasma — Research Highlights Growth, Revenue, and Consolidated ResultsGlobeNewswire
Nov-07-18 02:43PM Israel's Intec Pharma eyes revenue from Parkinson's drug in 2019Reuters
Jul-20-18 10:00AM 5 Favorite Biotech BetsInvestopedia
Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company's lead product candidate is Accordion Pill Carbidopa/Levodopa (AP-CDLD), which is in a Phase III clinical trial for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients. It is also developing Accordion Pill Zaleplon (AP-ZP) that is in a Phase III clinical trial for the treatment of insomnia, including sleep induction and for enhancing of sleep maintenance; Accordion Pill, which has completed a Phase I clinical trial for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug induced ulcers; and Accordion Pill platform with Cannabidiol and 9-Tetrahydrocannabinol, (AP-CBD/THC), which is in a Phase I clinical trial for the treatment of various indications, including low back neuropathic pain and fibromyalgia. The company was formerly known as Intec Pharmaceuticals (2000) Ltd. and changed its name to Intec Pharma Ltd. in March 2004. Intec Pharma Ltd. was founded in 2000 and is based in Jerusalem, Israel.
Stocks in other countries: United Kingdom India Canada Australia
Market Cap
Volume (24h)